WASHINGTON, July 31 -- The Securities and Exchange Commission issued the following litigation release (No. 1:24-cv-12316; D. Mass. filed Sept. 10, 2024) involving Dishant Gupta: * * * On July 29, 2025, the United States District Court for the District of Massachusetts entered a final consent judgment against New Jersey resident Dishant Gupta. The SEC previously charged Gupta with insider trading ahead of an announcement that Ipsen Biopharmaceuticals, Inc., then Gupta's employer, had agreed to   more